Cargando…

Feasibility study demonstrating that enzymatic template generation and amplification can be employed as a novel method for molecular antimicrobial susceptibility testing

BACKGROUND: Antimicrobial Susceptibility Testing (AST) is a methodology in which the sensitivity of a microorganism is determined via its inability to proliferate in the presence of an antimicrobial agent. Results are reported as minimum inhibitory concentrations (MICs). The present study demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sodowich, Bruce I, Zweitzig, Daniel R, Riccardello, Nichol M, O’Hara, S Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766015/
https://www.ncbi.nlm.nih.gov/pubmed/23941533
http://dx.doi.org/10.1186/1471-2180-13-191
_version_ 1782283444475133952
author Sodowich, Bruce I
Zweitzig, Daniel R
Riccardello, Nichol M
O’Hara, S Mark
author_facet Sodowich, Bruce I
Zweitzig, Daniel R
Riccardello, Nichol M
O’Hara, S Mark
author_sort Sodowich, Bruce I
collection PubMed
description BACKGROUND: Antimicrobial Susceptibility Testing (AST) is a methodology in which the sensitivity of a microorganism is determined via its inability to proliferate in the presence of an antimicrobial agent. Results are reported as minimum inhibitory concentrations (MICs). The present study demonstrates that measurement of DNA polymerase activity via Enzymatic Template Generation and Amplification (ETGA) can be used as a novel means of determining the MIC of a microbe to an antibiotic agent much sooner than the current standardized method. METHODS: Time course analysis of ETGA is presented from bacterial cultures containing antibiotic agents and compared to the end-point results of standard macrobroth method AST. RESULTS: MIC determinations from ETGA results at 4, 6, and 22 hours are compared to the MICs from the standard method and the results are shown to be in agreement. Additionally, reliable AST analysis using ETGA can be performed on bacteria harvested directly from spiked blood cultures. CONCLUSIONS: AST analysis with ETGA is shown to be equivalent to AST analysis using gene-specific qPCR assays against the measured microbe. Future development of this novel method for performing AST in a clinical setting is discussed.
format Online
Article
Text
id pubmed-3766015
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37660152013-09-08 Feasibility study demonstrating that enzymatic template generation and amplification can be employed as a novel method for molecular antimicrobial susceptibility testing Sodowich, Bruce I Zweitzig, Daniel R Riccardello, Nichol M O’Hara, S Mark BMC Microbiol Methodology Article BACKGROUND: Antimicrobial Susceptibility Testing (AST) is a methodology in which the sensitivity of a microorganism is determined via its inability to proliferate in the presence of an antimicrobial agent. Results are reported as minimum inhibitory concentrations (MICs). The present study demonstrates that measurement of DNA polymerase activity via Enzymatic Template Generation and Amplification (ETGA) can be used as a novel means of determining the MIC of a microbe to an antibiotic agent much sooner than the current standardized method. METHODS: Time course analysis of ETGA is presented from bacterial cultures containing antibiotic agents and compared to the end-point results of standard macrobroth method AST. RESULTS: MIC determinations from ETGA results at 4, 6, and 22 hours are compared to the MICs from the standard method and the results are shown to be in agreement. Additionally, reliable AST analysis using ETGA can be performed on bacteria harvested directly from spiked blood cultures. CONCLUSIONS: AST analysis with ETGA is shown to be equivalent to AST analysis using gene-specific qPCR assays against the measured microbe. Future development of this novel method for performing AST in a clinical setting is discussed. BioMed Central 2013-08-13 /pmc/articles/PMC3766015/ /pubmed/23941533 http://dx.doi.org/10.1186/1471-2180-13-191 Text en Copyright © 2013 Sodowich et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Sodowich, Bruce I
Zweitzig, Daniel R
Riccardello, Nichol M
O’Hara, S Mark
Feasibility study demonstrating that enzymatic template generation and amplification can be employed as a novel method for molecular antimicrobial susceptibility testing
title Feasibility study demonstrating that enzymatic template generation and amplification can be employed as a novel method for molecular antimicrobial susceptibility testing
title_full Feasibility study demonstrating that enzymatic template generation and amplification can be employed as a novel method for molecular antimicrobial susceptibility testing
title_fullStr Feasibility study demonstrating that enzymatic template generation and amplification can be employed as a novel method for molecular antimicrobial susceptibility testing
title_full_unstemmed Feasibility study demonstrating that enzymatic template generation and amplification can be employed as a novel method for molecular antimicrobial susceptibility testing
title_short Feasibility study demonstrating that enzymatic template generation and amplification can be employed as a novel method for molecular antimicrobial susceptibility testing
title_sort feasibility study demonstrating that enzymatic template generation and amplification can be employed as a novel method for molecular antimicrobial susceptibility testing
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766015/
https://www.ncbi.nlm.nih.gov/pubmed/23941533
http://dx.doi.org/10.1186/1471-2180-13-191
work_keys_str_mv AT sodowichbrucei feasibilitystudydemonstratingthatenzymatictemplategenerationandamplificationcanbeemployedasanovelmethodformolecularantimicrobialsusceptibilitytesting
AT zweitzigdanielr feasibilitystudydemonstratingthatenzymatictemplategenerationandamplificationcanbeemployedasanovelmethodformolecularantimicrobialsusceptibilitytesting
AT riccardellonicholm feasibilitystudydemonstratingthatenzymatictemplategenerationandamplificationcanbeemployedasanovelmethodformolecularantimicrobialsusceptibilitytesting
AT oharasmark feasibilitystudydemonstratingthatenzymatictemplategenerationandamplificationcanbeemployedasanovelmethodformolecularantimicrobialsusceptibilitytesting